High-Dose Inhaled Nitric Oxide as Adjunct Therapy in Cystic Fibrosis Targeting Burkholderia multivorans

BACKGROUND: Individuals with cystic fibrosis (CF) have persistent lung infections, necessitating the frequent use of antibiotics for pulmonary exacerbations. Some respiratory pathogens have intrinsic resistance to the currently available antibiotics, and any pathogen may acquire resistance over time...

Descripción completa

Detalles Bibliográficos
Autores principales: Bartley, Bethany L., Gardner, Kelly J., Spina, Stefano, Hurley, Bryan P., Campeau, David, Berra, Lorenzo, Yonker, Lael M., Carroll, Ryan W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334765/
https://www.ncbi.nlm.nih.gov/pubmed/32685229
http://dx.doi.org/10.1155/2020/1536714

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334765/
https://www.ncbi.nlm.nih.gov/pubmed/32685229
http://dx.doi.org/10.1155/2020/1536714

Ejemplares similares